Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
08/2003
08/07/2003US20030148330 Enhancing domains; polymerases; thermal stability
08/07/2003US20030148265 The factor allowing translocation is the homeodomain of antennapedia, and the viral protein can be from Flavivirus; fusion proteins as therapeutic agents
08/07/2003US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions
08/07/2003US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof
08/07/2003US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2
08/07/2003CA2477429A1 Targeted immunogens
08/07/2003CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003CA2474807A1 Transport peptides and uses therefor
08/07/2003CA2474759A1 Gene for peripheral arterial occlusive disease
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474457A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003CA2464869A1 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/06/2003EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
08/06/2003EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage
08/06/2003CN1434921A T2R taste receptors and genes encoding same
08/06/2003CN1434862A Improvement of nucleic acid vaccination
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1117155C Novel compounds
08/05/2003US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602502 Improved immunoassays of psychotomimetic drugs, narcotic drugs, tetrahydrocannabinols; use of the haptenic properties of psychoactive material; blood test N,N-Dimethyltryptamine and 5-Methoxy-N,N- Dimethyltryptamine
07/2003
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof
07/31/2003WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/31/2003WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003WO2002012286A3 Stress proteins and peptides and methods of use thereof
07/31/2003WO2001096870A3 Immunoassays for anti-hcv antibodies
07/31/2003US20030144480 Genetic engineering; medical diagnosis
07/31/2003US20030144474 T cell receptor and a biologically active polypeptide with different recognition biding sites connected by a peptide linker; designed to redirect the immune system against various diseases
07/31/2003US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders
07/31/2003US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product
07/31/2003US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes
07/31/2003US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents
07/31/2003US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation
07/31/2003US20030143626 Such as cyclin-dependent kinases and/or bax genes/proteins covalently linked to platform compound (thioredoxin); drug screening
07/31/2003US20030143589 Drug metabolizing enzymes
07/31/2003US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand
07/31/2003US20030143245 Multivalent streptococcal vaccine compositions and methods for use
07/31/2003US20030143193 Compositions and methods for modifying toxic effects of proteinaceous compounds
07/31/2003US20030143183 Combined use of a GLP-1 compound and another drug for treating dyslipidemia
07/31/2003CA2510751A1 Multimers of receptor-binding ligands
07/31/2003CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003CA2454358A1 Multimeric proteins and methods of making and using same
07/30/2003EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
07/30/2003EP1330528A2 Regulation of human serine-threonine protein kinase
07/30/2003EP1330475A2 Neuromedin u delta polypeptides
07/30/2003EP1330264A2 Vaccine for treating allergy
07/30/2003EP1330263A2 Method for down-regulating ige
07/30/2003EP1330260A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia
07/30/2003EP1165121B1 SUPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
07/30/2003CN1432652A Actinia neurotoxin gene and its application
07/30/2003CN1432651A Actinia neurotoxin gene and its application
07/30/2003CN1432650A Actinia neurotoxin gene and its application
07/30/2003CN1432649A Actinia neurotoxin gene and its application
07/30/2003CN1432647A Flat-chin sea snake long-chain neurotoxin gene and its expression and application
07/29/2003US6599508 Truncated papillomavirus L1 protein, vaccine
07/29/2003US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use
07/29/2003CA2133838C Immunotoxins directed against cd33 related surface antigens
07/29/2003CA2132982C Catalytic antibodies against cocaine and methods of using and producing same
07/29/2003CA2122044C Hiv immunotherapeutics
07/29/2003CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy
07/24/2003WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003WO2003060143A2 Efficient protein expression system
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/24/2003WO2003060080A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
07/24/2003WO2003060072A2 Recombinant polypeptides
07/24/2003WO2003060071A2 Albumin fusion proteins
07/24/2003WO2003060065A2 Adapter-directed display system
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use
07/24/2003WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof
07/24/2003WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof
07/24/2003WO2003059935A2 Methods for purifying protein
07/24/2003WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia
07/24/2003WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
07/24/2003WO2002102839A3 Novel g-protein coupled receptors and dna sequences thereof
07/24/2003WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003US20030139581 Protocadherin materials and methods
07/24/2003US20030139573 Lipid binding protein 3
07/24/2003US20030139365 Expression and export of angiogenesis inhibitors as immunofusins
07/24/2003US20030138836 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains
07/24/2003US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays
07/24/2003US20030138769 Immunogenic HBc chimer particles having enhanced stability
07/24/2003US20030138440 Multimeric proteins and methods of making and using same
07/24/2003US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
07/24/2003CA2841097A1 Albumin fusion proteins
07/24/2003CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003CA2471363A1 Albumin fusion proteins
07/24/2003CA2465178A1 Adapter-directed display system
07/24/2003CA2463008A1 Efficient protein expression system
07/23/2003EP1329507A1 Artificial protein having potentiated immunogenicity of epitope
07/23/2003EP1328653A2 Highly expressible genes
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 295